Project Grant HT94252310517
Award Date
7/1/23
Completion Date
6/30/27
Dollars Obligated
$2.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Oklahoma City, OK 73104, USA
Similar Awards
The Defense Health Agency awarded a $725,000 Project Grant to the University of Oklahoma Health Sciences Center to develop treatments for cognitive, motor, and sensory outcomes associated with mild traumatic brain injury and post-traumatic stress disorder. Funded through the Military Medical Research and Development program under the Cooperative Agreements and Other Transactions authority, this three-year award beginning April 15, 2023 will support research into modulating the NOP receptor...
This $309,279 Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research study on traumatic brain injury (TBI) and psychological health conducted by Florida State University. The primary objectives are to adapt the Ohio State University TBI Identification Method and the STAIR-NT intervention for first responders with TBI, analyze the data, and disseminate the study findings. Key sub-award activities...
This $2,699,157 federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, supports research to evaluate the effectiveness of a traumatic brain injury (TBI) whole blood test in improving assessment and triage for patients with mild TBI presenting to civilian emergency departments. The primary recipient, the University of Pittsburgh, will conduct this research over a performance period from July 1, 2025 to June 30,...
The University of Arizona, through the Arizona Board of Regents, was awarded a $3,004,651 Project Grant from the Defense Health Agency to develop a treatment for neuropsychological and memory impairments following moderate to severe traumatic brain injury. This grant, awarded under the Military Medical Research and Development (CFDA 12.420) program, funds a research project aimed at advancing scientific understanding and improving patient care for service members and veterans affected by...
The Defense Health Agency awarded a $3.755 million Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to investigate dual orexin antagonist treatment to prevent neurobehavioral sequelae of traumatic brain injury from April 1, 2023 to March 31, 2027. The Military Medical Research and Development program supports innovative medical research to improve warfighter health and transform public healthcare. Under this award,...
This $6,214,900 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports research on the role of genetic risk factors and immune response on neurovascular unit (NVU) function in post-traumatic brain injury (TBI) cognitive impairment. The primary awardee, the Scintillon Institute, a non-profit biomedical research organization in San Diego, California, will conduct this advanced scientific investigation over...
This federal Project Grant award of $737,899 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is supporting research by the University of Texas Health Science Center at San Antonio to develop a non-trauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The award has a performance period from September 1, 2024 to August 31, 2027. The project aims to...
The federal Project Grant award of $837,500.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research by The Feinstein Institutes for Medical Research on "OXYGEN CONSERVING REFLEX: A NOVEL MULTIMECHANISTIC THERAPEUTIC INTERVENTION FOR TBI." The research will investigate an innovative approach to address traumatic brain injury (TBI) by examining a novel oxygen conserving reflex. The award will support this...
The University of Oklahoma Health Sciences Center Division has been awarded a $144,992 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from November 1, 2024 to October 31, 2026, will support advanced biomedical research focused on "Vascular Regulation of Immunosuppression in Glioblastoma." The funding will enable the university to conduct...
The federal Project Grant award of $810,000.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research on "EARLY NEUROMODULATION FOR COGNITIVE RECOVERY AND REHABILITATION IN TRAUMATIC BRAIN INJURY" at the University of Cincinnati. The grant, awarded on Nov 1, 2024, with a completion date of Oct 31, 2027, will fund scientific investigations exploring innovative approaches to disease prevention, diagnosis, treatment,...